STING1 and breast cancer: An early in vitro study showed that mafosfamide, a CTX analog that spontaneously degrades to 4-hydroxy-CTX, upregulates the production of IFN-I in two out of the four human breast cancer cell lines examined and that STING knockdown reduces the level of IFN-I expression [17].